Harbour JW - Search Results

1

Genomic evolution of uveal melanoma arising in ocular melanocytosis.

Durante MA, Field MG, Sanchez MI, Covington KR, Decatur CL, Dubovy SR, Harbour JW. Durante MA, et al. Among authors: harbour jw. Cold Spring Harb Mol Case Stud. 2019 Aug 1;5(4):a004051. doi: 10.1101/mcs.a004051. Print 2019 Aug. Cold Spring Harb Mol Case Stud. 2019. PMID: 31186267 Free PMC article.

2

Genomic, prognostic, and cell-signaling advances in uveal melanoma.

Harbour JW. Harbour JW. Am Soc Clin Oncol Educ Book. 2013:388-91. doi: 10.14694/EdBook_AM.2013.33.388. Am Soc Clin Oncol Educ Book. 2013. PMID: 23714557 Free PMC article. Review.

3

A prognostic test to predict the risk of metastasis in uveal melanoma based on a 15-gene expression profile.

Harbour JW. Harbour JW. Methods Mol Biol. 2014;1102:427-40. doi: 10.1007/978-1-62703-727-3_22. Methods Mol Biol. 2014. PMID: 24258991 Free PMC article.

4

A molecular revolution in uveal melanoma: implications for patient care and targeted therapy.

Harbour JW, Chao DL. Harbour JW, et al. Ophthalmology. 2014 Jun;121(6):1281-8. doi: 10.1016/j.ophtha.2013.12.014. Epub 2014 Jan 28. Ophthalmology. 2014. PMID: 24480708 Free PMC article.

5

Recent developments in prognostic and predictive testing in uveal melanoma.

Field MG, Harbour JW. Field MG, et al. Among authors: harbour jw. Curr Opin Ophthalmol. 2014 May;25(3):234-9. doi: 10.1097/ICU.0000000000000051. Curr Opin Ophthalmol. 2014. PMID: 24713608 Free PMC article. Review.

6

GNAQ/11 mutations in uveal melanoma: is YAP the key to targeted therapy?

Field MG, Harbour JW. Field MG, et al. Among authors: harbour jw. Cancer Cell. 2014 Jun 16;25(6):714-5. doi: 10.1016/j.ccr.2014.05.028. Cancer Cell. 2014. PMID: 24937456 Free PMC article.

7

Prognostic parameters in uveal melanoma and their association with BAP1 expression.

van Essen TH, van Pelt SI, Versluis M, Bronkhorst IH, van Duinen SG, Marinkovic M, Kroes WG, Ruivenkamp CA, Shukla S, de Klein A, Kiliç E, Harbour JW, Luyten GP, van der Velden PA, Verdijk RM, Jager MJ. van Essen TH, et al. Among authors: harbour jw. Br J Ophthalmol. 2014 Dec;98(12):1738-43. doi: 10.1136/bjophthalmol-2014-305047. Epub 2014 Aug 21. Br J Ophthalmol. 2014. PMID: 25147369 Free PMC article.

8

Skewed expression of the genes encoding epigenetic modifiers in high-risk uveal melanoma.

Herlihy N, Dogrusöz M, van Essen TH, Harbour JW, van der Velden PA, van Eggermond MC, Haasnoot GW, van den Elsen PJ, Jager MJ. Herlihy N, et al. Among authors: harbour jw. Invest Ophthalmol Vis Sci. 2015 Jan 15;56(3):1447-58. doi: 10.1167/iovs.14-15250. Invest Ophthalmol Vis Sci. 2015. PMID: 25593028 Free PMC article.

9

Hydroxyapatite versus polyethylene orbital implants for patients undergoing enucleation for uveal melanoma.

Chao DL, Harbour JW. Chao DL, et al. Among authors: harbour jw. Can J Ophthalmol. 2015 Apr;50(2):151-4. doi: 10.1016/j.jcjo.2014.11.007. Can J Ophthalmol. 2015. PMID: 25863856

10

EMT-associated factors promote invasive properties of uveal melanoma cells.

Asnaghi L, Gezgin G, Tripathy A, Handa JT, Merbs SL, van der Velden PA, Jager MJ, Harbour JW, Eberhart CG. Asnaghi L, et al. Among authors: harbour jw. Mol Vis. 2015 Aug 25;21:919-29. eCollection 2015. Mol Vis. 2015. PMID: 26321866 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

229 results

Search Page